# Mechanism of Action Class Usage

Generated on 2025-10-19 from `src/data/articles.json`. Each mechanism string was split on semicolons and trimmed before counting.

Counts are standardized using `notes and plans/standardized MOAs.md` to consolidate synonymous mechanism labels.

## Ranked classes

1. **5-HT2A receptor agonist** — 79 articles
2. **Dopamine-norepinephrine reuptake inhibitor** — 52 articles
3. **GABA-A receptor positive allosteric modulator (benzodiazepine site)** — 52 articles
4. **NMDA receptor antagonist** — 52 articles
5. **Dopamine-norepinephrine releasing agent** — 30 articles
6. **Serotonin-dopamine-norepinephrine releasing agent** — 27 articles
7. **5-HT2A receptor partial agonist** — 21 articles
8. **Dopamine-norepinephrine reuptake inhibitor (potent)** — 21 articles
9. **μ-Opioid receptor agonist (full)** — 21 articles
10. **CB1 and CB2 receptor full agonist** — 20 articles
11. **μ-Opioid receptor agonist** — 20 articles
12. **5-HT2A receptor agonist (potent)** — 18 articles
13. **Serotonin releasing agent** — 18 articles
14. **5-HT2B receptor agonist (cardiotoxic)** — 17 articles
15. **Monoamine oxidase inhibitor** — 15 articles
16. **Stimulant (uncertain mechanism)** — 15 articles
17. **Serotonin reuptake inhibitor** — 14 articles
18. **Combination mechanism** — 13 articles
19. **Dopamine reuptake inhibitor** — 13 articles
20. **Acetylcholine precursor** — 9 articles
21. **GABA-A receptor positive allosteric modulator** — 9 articles
22. **GABA-B receptor agonist** — 9 articles
23. **Muscarinic acetylcholine receptor antagonist** — 9 articles
24. **Prodrug (LSD)** — 9 articles
25. **5-HT2C receptor agonist** — 8 articles
26. **5-HT2C receptor partial agonist** — 8 articles
27. **Norepinephrine reuptake inhibitor** — 8 articles
28. **Serotonin-dopamine-norepinephrine reuptake inhibitor** — 8 articles
29. **AMPA receptor positive allosteric modulator** — 6 articles
30. **G-protein-biased μ-opioid receptor agonist (partial)** — 6 articles
31. **GABA-A receptor positive allosteric modulator (non-benzodiazepine site)** — 6 articles
32. **Prodrug (morphine)** — 6 articles
33. **Serotonin reuptake inhibitor (weak)** — 6 articles
34. **Unclear mechanism** — 6 articles
35. **κ-opioid receptor agonist** — 6 articles
36. **5-HT1A receptor agonist** — 5 articles
37. **Adrenergic receptor agonist** — 5 articles
38. **Dopamine releasing agent** — 5 articles
39. **κ-opioid receptor antagonist** — 5 articles
40. **5-HT2B receptor partial agonist** — 4 articles
41. **GABA-A receptor agonist (at high concentration)** — 4 articles
42. **Gamma-hydroxybutyrate receptor agonist** — 4 articles
43. **Voltage-gated calcium channel alpha-2-delta subunit ligand** — 4 articles
44. **δ-opioid receptor antagonist** — 4 articles
45. **5-HT2B receptor agonist** — 3 articles
46. **CB1 and CB2 receptor partial agonist** — 3 articles
47. **Glutathione precursor** — 3 articles
48. **H1 histamine receptor antagonist** — 3 articles
49. **Monoamine oxidase B inhibitor** — 3 articles
50. **Norepinephrine releasing agent** — 3 articles
51. **Norepinephrine releasing agent and reuptake inhibitor** — 3 articles
52. **Phospholipid synthesis enhancer** — 3 articles
53. **Serotonin receptor agonist** — 3 articles
54. **Serotonin releasing agent and reuptake inhibitor** — 3 articles
55. **Serotonin reuptake and receptor modulator** — 3 articles
56. **Serotonin-norepinephrine reuptake inhibitor** — 3 articles
57. **Sodium channel blocker** — 3 articles
58. **TAAR1 agonist** — 3 articles
59. **Adenosine receptor antagonist** — 2 articles
60. **Cytochrome P450 3A4 inhibitor** — 2 articles
61. **D2 dopamine receptor agonist (weak)** — 2 articles
62. **GABA-A receptor agonist** — 2 articles
63. **GABA-A receptor positive allosteric modulator (barbiturate site)** — 2 articles
64. **H1 histamine receptor inverse agonist** — 2 articles
65. **Imidazoline receptor agonist** — 2 articles
66. **Metabotropic glutamate receptor agonist** — 2 articles
67. **Methyl group donor** — 2 articles
68. **Nicotinic acetylcholine receptor antagonist** — 2 articles
69. **Phosphocreatine source** — 2 articles
70. **Potassium channel opener** — 2 articles
71. **Prodrug (O-desmethyltramadol)** — 2 articles
72. **Prodrug (psilocin)** — 2 articles
73. **Serotonin releasing agent (weak)** — 2 articles
74. **Sigma-1 receptor agonist** — 2 articles
75. **Voltage-gated potassium channel blocker** — 2 articles
76. **μ-Opioid receptor agonist (limited data)** — 2 articles
77. **5-HT1A receptor full agonist** — 1 article
78. **5-HT1A receptor partial agonist** — 1 article
79. **5-HT2A receptor agonist (speculated)** — 1 article
80. **5-HT2A receptor antagonist** — 1 article
81. **5-HT2C receptor full agonist** — 1 article
82. **5-HT6 receptor agonist** — 1 article
83. **Acetylcholinesterase inhibitor** — 1 article
84. **AMPA receptor modulator** — 1 article
85. **AMPA receptor negative allosteric modulator** — 1 article
86. **Androgen receptor agonist** — 1 article
87. **Anti-parkinsonian** — 1 article
88. **Aromatase inhibitor** — 1 article
89. **Beta-adrenergic receptor antagonist** — 1 article
90. **CB1 and CB2 receptor agonist (speculated)** — 1 article
91. **Central nervous system depressant** — 1 article
92. **Cystine-glutamate antiporter substrate** — 1 article
93. **D2 dopamine receptor agonist** — 1 article
94. **Deliriant (uncertain mechanism)** — 1 article
95. **Dopamine receptor agonist (low affinity)** — 1 article
96. **Dopamine releasing agent and reuptake inhibitor** — 1 article
97. **Dopamine synthesis enhancer** — 1 article
98. **Estrogen receptor agonist** — 1 article
99. **GABA-A receptor agonist (stereoselective)** — 1 article
100. **GABA-A receptor positive allosteric modulator (proconvulsant site)** — 1 article
101. **Glutamate receptor modulator** — 1 article
102. **Glycine receptor positive allosteric modulator** — 1 article
103. **Melatonin receptor agonist** — 1 article
104. **Mood stabilizer** — 1 article
105. **Muscarinic acetylcholine receptor agonist** — 1 article
106. **N-methyl-D-aspartate receptor agonist** — 1 article
107. **NF-kB inhibitor** — 1 article
108. **Nicotinamide methyltransferase substrate** — 1 article
109. **Nicotinic acetylcholine receptor agonist** — 1 article
110. **Nitric oxide activity enhancer** — 1 article
111. **NMDA receptor antagonist (noncompetitive)** — 1 article
112. **NMDA receptor antagonist (selective)** — 1 article
113. **NMDA receptor modulator** — 1 article
114. **Nociceptin receptor agonist** — 1 article
115. **Nootropic (uncertain mechanism)** — 1 article
116. **Phospholipase modulator** — 1 article
117. **Precursor to L-DOPA** — 1 article
118. **Prodrug (4-HO-MiPT)** — 1 article
119. **Prodrug (6-monoacetylmorphine)** — 1 article
120. **Prodrug (cytidine)** — 1 article
121. **Prodrug (dihydromorphine)** — 1 article
122. **Prodrug (levorphanol)** — 1 article
123. **Prodrug (muscimol)** — 1 article
124. **Prodrug (pCPA)** — 1 article
125. **Prodrug (R-4618)** — 1 article
126. **Prostaglandin synthetase inhibitor** — 1 article
127. **Serotonin 5-HT3 receptor antagonist** — 1 article
128. **Serotonin receptor partial agonist** — 1 article
129. **Serotonin-norepinephrine releasing agent** — 1 article
130. **VMAT2 inhibitor** — 1 article
131. **δ-opioid receptor agonist** — 1 article
132. **μ-Opioid receptor agonist (partial)** — 1 article
133. **μ-Opioid receptor agonist (peripherally-restricted)** — 1 article
134. **μ-Opioid receptor antagonist** — 1 article
